Rebekah Gould - Concepedia

Author

Rebekah Gould

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Gould, Rebekah, Gould, Rebekah E., Hongxia Sun, R Gould, R. Gould, R.E. Gould, Rebekah E. Gould, Rebekah Gould

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Yale Cancer Center University of California, San Francisco Yale University Silesian University of Technology

About

Rebekah Gould is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	919
2	Biostatistics	2	2	138
3	Health Sciences	1	1	112
4	Public Health	1	1	26
5	Obstetrics	1	1	45

Rebekah Gould

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Journal of Clinical Oncology Surgical OncologyOncologyPhenotypic SubsetsBreast OncologyBreast Cancer Subtype	2017	687
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer Bruno V. Sinn, Chunxiao Fu, Rosanna Lau, npj Breast Cancer	2019	350
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy S.J. Luen, Roberto Salgado, Maria Vittoria Dieci, Annals of Oncology	2018	196
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy Florentia Peintinger, Bruno V. Sinn, Christos Hatzis, Modern Pathology Breast OncologyNeoadjuvant ChemotherapyMedicineCancer RegistrationBiostatistics	2015	112
Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer Christos Hatzis, W. Fraser Symmans, Ya Zhang, Clinical Cancer Research	2015	63
The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues Michał Marczyk, Chunxiao Fu, Rosanna Lau, BMC Cancer	2019	56
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy Lili Du, Christina Yau, Lamorna Brown Swigart, Annals of Oncology Chemo-endocrine TherapyBreast OncologyMedicinePharmacologyGynecology	2021	45
Changes in Surgical Management of the Axilla Over 11 Years – Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial Judy C. Boughey, Hongmei Yu, Catherine Lu Dugan, Annals of Surgical Oncology Surgical OncologyBreast OncologyBreast Cancer PatientsMedicineClinical Trials	2023	37
Abstract GS5-01: Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer: A multi-center pooled analysis Christina Yau, Marieke van der Noordaa, Jane Wei, Cancer Research Prognostic EvaluationSurgical OncologyBreast OncologyCancer EpidemiologyMedicine	2020	26
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer Gloria V. Echeverria, Shirong Cai, Yizheng Tu, npj Breast Cancer	2023	19

Page 1